Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients: A Phase 2A, Randomized, Placebo-Controlled Trial
Latest Information Update: 18 May 2023
At a glance
- Drugs Phentermine/topiramate (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 12 May 2023 Planned End Date changed from 30 Sep 2022 to 30 Jun 2024.
- 12 May 2023 Planned primary completion date changed from 30 Jun 2022 to 30 Jun 2024.
- 28 Jan 2021 New trial record